These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20217564)

  • 1. Topical application of siRNA targeting cutaneous dendritic cells in allergic skin disease.
    Azuma M; Ritprajak P; Hashiguchi M
    Methods Mol Biol; 2010; 623():373-81. PubMed ID: 20217564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells.
    Ritprajak P; Hashiguchi M; Azuma M
    Mol Ther; 2008 Jul; 16(7):1323-30. PubMed ID: 18461054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells.
    Suzuki M; Zheng X; Zhang X; Zhang ZX; Ichim TE; Sun H; Nakamura Y; Inagaki A; Beduhn M; Shunnar A; Garcia B; Min WP
    J Allergy Clin Immunol; 2010 Mar; 125(3):737-43, 743.e1-743.e6. PubMed ID: 20226305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA specific delivery system for targeting dendritic cells.
    Zheng X; Vladau C; Shunner A; Min WP
    Methods Mol Biol; 2010; 623():173-88. PubMed ID: 20217551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
    Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
    Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of RNA interference on CD80 and CD86 expression in bone marrow-derived murine dendritic cells.
    Gu X; Xiang J; Yao Y; Chen Z
    Scand J Immunol; 2006 Dec; 64(6):588-94. PubMed ID: 17083614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of allergic responses by CD40 gene silencing.
    Suzuki M; Zheng X; Zhang X; Ichim TE; Sun H; Kubo N; Beduhn M; Shunnar A; Garcia B; Min WP
    Allergy; 2009 Mar; 64(3):387-97. PubMed ID: 19175598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of PD-L2/B7-DC by Topical Application of Small Interfering RNA Inhibits Elicitation of Contact Hypersensitivity.
    Furusawa E; Ohno T; Nagai S; Noda T; Komiyama T; Kobayashi K; Hamamoto H; Miyashin M; Yokozeki H; Azuma M
    J Invest Dermatol; 2019 Oct; 139(10):2164-2173.e1. PubMed ID: 30978356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice.
    Darcan-Nicolaisen Y; Meinicke H; Fels G; Hegend O; Haberland A; Kühl A; Loddenkemper C; Witzenrath M; Kube S; Henke W; Hamelmann E
    J Immunol; 2009 Jun; 182(12):7501-8. PubMed ID: 19494273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse.
    Takanashi M; Oikawa K; Sudo K; Tanaka M; Fujita K; Ishikawa A; Nakae S; Kaspar RL; Matsuzaki M; Kudo M; Kuroda M
    Gene Ther; 2009 Aug; 16(8):982-9. PubMed ID: 19474812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
    Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
    J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice.
    Atarashi K; Kabashima K; Akiyama K; Tokura Y
    Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNA binding protein tristetraprolin influences the activation state of murine dendritic cells.
    Bros M; Wiechmann N; Besche V; Art J; Pautz A; Grabbe S; Kleinert H; Reske-Kunz AB
    Mol Immunol; 2010 Feb; 47(5):1161-70. PubMed ID: 19945750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
    Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
    Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
    Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
    Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
    Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
    Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.
    Kamimura Y; Iwai H; Piao J; Hashiguchi M; Azuma M
    J Immunol; 2009 Mar; 182(5):2708-16. PubMed ID: 19234165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripartite siRNA micelles as controlled delivery systems for primary dendritic cells.
    Boudier A; Aubert-Pouëssel A; Gérardin C; Devoisselle JM; Bégu S; Louis-Plence P; Quentin J; Jorgensen C
    Drug Dev Ind Pharm; 2009 Aug; 35(8):950-8. PubMed ID: 19274590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune modulation through RNA interference-mediated silencing of CD40 in dendritic cells.
    Karimi MH; Ebadi P; Pourfathollah AA; Soheili ZS; Samiee S; Ataee Z; Tabei SZ; Moazzeni SM
    Cell Immunol; 2009; 259(1):74-81. PubMed ID: 19589505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.